<DOC>
	<DOCNO>NCT02231086</DOCNO>
	<brief_summary>This study aim determine oncological effectiveness adjuvant HIPEC , use intraperitoneal oxaliplatin concomitant i.v . 5-FU/LV , follow curative resection T4 intra-abdominally perforate Colon cancer prevent development peritoneal carcinomatosis addition standard adjuvant systemic treatment . Hypothesis : The hypothesis adjuvant HIPEC precede routine adjuvant systemic therapy use i.p . oxaliplatin concomitant i.v . 5-FU/LV follow curative resection T4 intra-abdominally perforate colon cancer reduce development peritoneal carcinomatosis comparison standard adjuvant systemic treatment alone .</brief_summary>
	<brief_title>Adjuvant HIPEC High Risk Colon Cancer</brief_title>
	<detailed_description>Background : The peritoneum second common site recurrence patient colon cancer . Early detection peritoneal carcinomatosis ( PC ) image difficult adjuvant systemic treatment seem affect peritoneal dissemination contrast haematogenous dissemination liver lung . Of patient eventually present clinically apparent PC , quarter potentially curable disease . The curative option cytoreductive surgery hyperthermic intraperitoneal chemotherapy ( CR/HIPEC ) , effectiveness depend highly extent disease associate considerable complication rate . These clinical problem underline need effective adjuvant intraperitoneal therapy high risk colon cancer patient order prevent development PC treatment subclinical stage . Study design : This multicentre study 176 eligible patient randomize adjuvant HIPEC follow adjuvant systemic chemotherapy experimental arm , standard adjuvant systemic chemotherapy alone control arm . Adjuvant HIPEC perform preferably simultaneously within 10 day resection primary tumour , either laparoscopy open approach , similar technique use resection primary tumour . If adjuvant HIPEC perform within 10 day ( i.e . complicate postoperative course ) , procedure delay 5 8 week postoperatively . Subsequently , patient receive routine adjuvant chemotherapy ( CAPOX ) within 3 week HIPEC . Diagnostic laparoscopy perform routinely 18 month postoperatively arm study patient without evidence disease base routine follow-up use CT image CEA . If peritoneal carcinomatosis find stag laparoscopy , CR/ HIPEC perform patient maximum 5 involved region without evidence systemic disease . Study population : Patients underwent intentionally curative resection T4N0-2M0 intra-abdominally perforate colon cancer . Intervention : Adjuvant HIPEC procedure : access abdominal cavity laparoscopy laparotomy general anaesthesia , adhesiolysis necessary , complete stag intra-abdominal cavity , position in- outflow catheter , perfusion minimum 2l isotonic dialysis fluid flow rate 1-2l/min inflow temperature 42-43˚C . Before begin HIPEC , 5-fluorouracil 400 mg/m2 leucovorin 20 mg/m2 administer intravenously potentiate oxaliplatin activity . Oxaliplatin ( 460 mg/m2 ) add perfusate attain least 42 degree inflow temperature total 30 minute perfusion time . Outcomes : Primary endpoint peritoneal recurrence-free survival 18 month . Secondary endpoint number participant adverse event measure safety tolerability , incidence PC end follow-up without concomitant liver/lung metastasis , percentage false negative CT 18 month ( second look laparoscopy/laparotomy gold standard ) , disease-free survival , overall survival , quality life cost .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>age 18 75 year Intention start routine adjuvant systemic therapy adequate clinical condition undergo simultaneous HIPEC laparoscopy relaparotomy HIPEC within either 10 day week 58 primary resection write informed consent white blood cell count least 3000/mm3 , platelet count least 100.000/mm3 bleed diathesis coagulopathy normal creatinine creatinine clearance least 50 ml/min postoperative complication interfere adjuvant HIPEC within 8 week ( i.e . persist intraabdominal abscess , significant fascial dehiscence , enteric fistula ) intention start routine adjuvant systemic therapy liver and/or lung metastasis pregnant lactate woman unstable uncompensated respiratory cardiac disease serious active infection concurrent chemotherapy hypersensitivity fluorouracil , folinic acid another substance leucovorin oxaliplatin stomatitis , ulceration mouth gastrointestinal tract . severe diarrhea severe hepatic / renal dysfunction . plasma bilirubin concentration great 85 μmol/l . pernicious anemia anaemia due vitamin B12 deficiency . peripheral sensory neuropathy functional impairment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Chemotherapy , Adjuvant</keyword>
	<keyword>Laparoscopy</keyword>
	<keyword>Peritoneal Lavage</keyword>
	<keyword>HIPEC</keyword>
</DOC>